Leadership

Mr. Brown has over 20 years of experience as a sales and marketing leader, helping businesses and clients grow and scale. Mr. Brown has proven expertise in growing business enterprises and successfully building shareholder value. Over his career Mr. Brown has helped bring numerous brands to shelf at the largest retailers in the world, and products to market both domestically and internationally.  He has served in leadership roles that include both sales, business development, and marketing.  He is a frequent panel speaker and consultant on subjects relating to consumer packaged goods (CPG), channel  and go to market strategy, and brand positioning. Mr. Brown has also served as an Entrepreneur In Residence and a Mentor in the CONNECT Springboard program providing guidance to entrepreneurs and management teams in San Diego.

Mr. Cahill is a published author and scientist. He has worked closely with his Alma Mater, the California Institute of Technology, as well as NASA’s Jet Propulsion Laboratory (JPL). He has partnered – and co-authored – with JPL’s Chief Scientist Dr. Mark Simons focusing on Deep Learning-based natural disaster detection and damage mapping with interferometric synthetic-aperture radar satellite coherence time series data. This research resulted in a paper published in the Journal of the Institute of Electrical and Electronics Engineers. In addition, Mr. Cahill has worked under grants from the Defense Advanced Research Projects Agency (DARPA) with Dr. Danny Petrasek in Medical Engineering, focusing on using machine learning in analysis of the gut microbiome of patients with Metabolic Syndrome, also known as Syndrome X. This research has shown extreme promise in the determination of individual patient’s likelihood for obesity and other diseases well before current state-of-the-art testing methods. Mr. Cahill graduated from the California Institute of Technology (Caltech) with a Bachelor of Science degree in Computer Science, with concentration in machine learning and data science.

Mr. Burleson is an analytical chemist specializing in chromatography and mass spectrometry. Earning his Bachelor’s of Science degree in Chemistry from the California Institute of Technology, he built a novel electrospray ionization source for sampling biotic precursor molecules at liquid-liquid interfaces under the guidance of Professor J.L. Beauchamp. Additionally, he helped to develop Caltech’s first-ever Laser Ablation-Inductively Coupled Plasma Mass Spectrometer instrument to determine trace elemental compositions of geological material. This research in the labs of Professors Nathan Dalleska and Paul Asimow helped to provide a new pathway for determining magmatic origins of geosamples from around the world. Mr. Burleson also worked closely with the late Nobel Laureate Professor Robert H. Grubbs studying organic polymers and analytical techniques.

Mr. Cahill was the CEO and founder of Centaur Corporation. As a leader in the semiconductor industry, his firm had sales in excess of $1 billion for 13 years in a row. He has founded numerous companies and has lead sales organizations for over 30 years. He serves as a Trustee for Rose Hulman Institute of Technology and the University of California, Irvine. He also sits on the executive committee of numerous philanthropic entities. Mr. Cahill holds a bachelors degree in Electrical Engineering from Rose Hulman Institute of Technology and a Masters Degree in Business Administration from Indiana State University.

Dr. Weimann has been involved in the development of transdermal patches and patch technology for over three decades. He has successfully developed a plethora of transdermal patch formulations starting in the early 1980s including two FDA approved generic transdermal systems: the Nitroglycerine patch and the Estrogen patch, both presently marketed by Mylan Pharmaceuticals, Inc. Dr. Wiemann holds a PhD in Physical Chemistry from Poznan University and did Post-Doctoral training at Kansas University and the University of Missouri – Kansas City. He has authored 15 peer-reviewed publications and has received numerous patents that have relevance to the business of the Company.

Mr. Chen is a FinTech entrepreneur with extensive research and development experience in web and mobile software, artificial intelligence, computer and embedded systems. James is the CTO of Derivatas, a leading valuation software and services vendor for venture capitals and startups. He cofounded Oldhamii Capital, an investment company specializing in the acquisition, renovation and operation of residential and commercial real estate. He also founded and serve as the Chief Investment Officer for Ntuitive Capital, a hedge fund that uses a proprietary hedging strategy to simultaneously expose investors to both the stock market and real estate, boosting returns while minimizing downside risk. James was formerly with the global management consulting firm McKinsey &Company, where he specialized in strategy and operations for some of the largest technology companies. James holds a PhD in Electrical Engineering from Stanford University and is a graduate of the Summer Institute for Entrepreneurship from the Stanford Graduate School of Business.

Dr. Webber has decades of executive level experience in the highly regulated pharmaceutical space. Among his career assignments, Dr. Webber served within FDA’s Center for Drug Evaluation and Research as the Director of the Office of Pharmaceutical Science, Director of the Office of Generic Drugs, and Director of the Office of Biotechnology Products. More recently, Dr. Webber served as the Senior Director of Rx Regulatory Affairs for Perrigo Co. PFC, a multinational OTC and Pharmaceutical product distributor and manufacturer. Dr. Webber received his Ph.D. in Biological Chemistry from the University of Michigan and his B.S. degree in Chemistry from the University of Denver.  

Mr. Gluck is a member of the Patent Bar, and Licensed to Practice in New York, California, and before the Court of Appeals for the Federal Circuit. Mr. Gluck has an extensive background in Patent law and is responsible for more than 1,150 Patented Public Record-listed Documents. Before founding PATNSTR®, APC he practiced law at several national and regional law firms such as Greenberg Traurig, LP, Baker & Hostetler LLP and Brown Rudnick LLP. He has held the Chief Patent Counsel (Assistant General Counsel & Corporate Secretary) position at medical device companies such as Advanced Medical Optics (AMO®), where he won a $250M patent litigation case against Alcon. Mr. Gluck successfully interfaces with international service providers and government authorities to extend patent rights globally and serves as an expert witness in patent cases. Peter earned his Master of Intellectual Property and his J.D. at the Franklin Pierce Law Center of the University of New Hampshire and his AB in Biology and Philosophy at Bates College. 

Mr. Bell is the Chairman of Canopy Rivers Corp (TSX) and Director and Past-Chair of Canopy Growth Corp. (TSX, NYSE) He is managing Partner of Onbelay Capital Inc., a private equity and investment company based in Cambridge Canada. He was founder, owner and CEO of Shred-Tech Inc., a global Manufacturer of Shredding and recycling equipment and creator of the mobile shredding Industry. He was owner and CEO of Polymer Technologies Inc. a global manufacturer of auto parts. He was Chairman and principal shareholder of BSM Technologies Inc. (TSX) a fleet management Company, He was CEO and director of ATS Automation (TSX) with 23 plants global plants. A believer in Community service John has contributed to numerous organizations including Cambridge Memorial Hospital (Chairman), Waterloo Regional Police (Chairman), Waterloo Region Prosperity Council (Chairman), Crohns and Colitis Canada (National Secretary). He is currently a Governor of the Stratford Festival.

Mr. Cullen has an extensive banking and finance background. He is the president and founder of Harvard Investment Group. Harvard Investment Group was founded in 1995 to make direct investments and provide consulting services to start up corporations and other ventures. Since its inception, Harvard Investment Group and Mr. Cullen have been the lead investor in dozens of transactions with a combined value of approximately $100 million. Mr. Cullen holds a bachelors degree in Mechanical Engineering from Rose Hulman Institute of Technology and a Masters Degree in Business Administration from Harvard Business School. 

Nick Salvato is a Los Angeles based entrepreneur specializing in private equity, real estate and health care.  Mr. Salvato has experience in the field of real estate finance, capital raising, investment, development, and management.  He co-founded several real estate venture funds and has owned, operated and/or managed approximately 500 real estate assets.   In the field of private equity, Mr. Salvato has been the lead investor on over a dozen different companies.  He is the founder and principal of Restored Life Continuum of Care, a health-care enterprise based in the Midwest United States.  Mr. Salvato’s organization specializes in addiction and mental health recovery, offering a full continuum of medical/mental health services--most notably---Medication Assisted Treatment or MAT.  Mr. Salvato has strategically partnered with and invested in Remy Biosciences to develop medical-grade Biodermal technology to serve his ever-growing client base in the MAT field.